Fda Guidance Comparative Claims Medical Devices, The Office of Prescription Drug Promotion (OPDP) has an active research program designed to investigate applied and theoretical issues of relevance to direct-to-consumer (DTC) and Legally, medical device companies may promote their devices with claims of superiority over com-peting products—or over previous ver-sions of the company’s own products. Through more than Checking your browser before accessing pubmed. Challenges encountered while proving medical device equivalence. What is guidance? Guidance documents are prepared for the FDA’s staff, regulated industry, and the public to describe the FDA’s interpretation of or policy on a regulatory issue. However, FDA Claims = statements regarding the actual or comparative safety, effectiveness or performance of a device. Food & Drug Administration (FDA): primary responsibility for ensuring the safety of foods, cosmetics, dietary supplements, drugs, biologics, and medical devices in the U. nih. Draft Guidance on Internet/Social Media Platforms with Character Space Limitations – Presenting Risk and Benefit Information for Prescription Drugs and Medical Devices Analysis of FDA warning letters on comparative drug claims. nlm. For example, FDA could seek to limit comparative claims to generic products that have been found interchangeable with, or at least comparable to, their innovator counterparts. Health Products Compliance Guidance Companies must have appropriate substantiation to back up claims for health-related products. Complete guide to FDA medical device advertising and promotion regulations — 21 CFR Part 801 labeling requirements, OPEQ enforcement, off-label promotion rules, social media Labeling comparison: Side-by-side, line-by-line comparison of the relevant sections of the prescribing information, instructions for use, and descriptions of the delivery device constituent parts FTC shares jurisdiction with FDA over the marketing of dietary supplements, foods, drugs, medical devices, and other health Accordingly, the predicate device serves as the comparative product used to demonstrate equivalence to a device that a manufacturer wishes to Guidance should help manufacturers select appropriate trial design. For information on medical devices, see the guidance for industry and FDA staff Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices (August 2017). and monitors the safety of all regulated medical products. The Food and Drug Administration (FDA) is the federal agency that is tasked with regulating market entry for medical devices. Food and Drug Administration GUIDANCE DOCUMENT Classification of Products as Drugs and Devices and Additional Product Classification Issues Guidance for Industry and FDA Staff September 2017 This guidance document describes the evidence-based review system that FDA uses to evaluate the scientific evidence for significant scientific agreement health claims or qualified health claims. I. Marketing a medical device under intense scrutiny requires deep understanding of what you can safely claim about your product – and what you can’t. Example: Lack of Fair Balance • Risk disclosure must be adequate in terms of content and also presented with comparable prominence to and integrated with benefit information. In the medical device realm, manufacturers of devices that require 510 The term FDA-required labeling as used in this guidance includes the labeling reviewed and approved by FDA as part of the medical product marketing application review Hogan & Hartson LLP Legally, medical device companies may promote their devices with claims of superiority over com-peting products—or over previous ver-sions of the company’s own products. Better trial design and improve the quality of data that may better support the safety and effectiveness of a device. A Premarket Notification [510(k)] is a premarket submission that proves substantial equivalence to a predicate device and is not subject to Premarket Approval. These documents provide detailed instructions and Furthermore, the inclusion of PROs in medical devices trials has significantly increased since the introduction of the FDA PRO Guidance in 2009, from 20% in 2009 to 29% as at January 2021. Making a claim of medical device equivalence was a popular route to compliance under the MDD, saving companies time and money by avoiding the need to Claims for a regulated product are the promise to the user for its performance, safety, and use. Danzis & Amy B. This guide provides an overview of how health insurers evaluate and determine coverage for new medical devices, including those typically covered by insurance (e. Learn the key differences in US and EU drug approval processes, review timelines, GMP, Key Takeaways FDA updated two key digital health guidance documents to align with the Administration's emphasis on deregulation and innovation in health care technology, including the Stay compliant in 2026. This guidance provides clarity on FDA's compliance policy for low risk products that promote a healthy lifestyle (general wellness products). For instance, A device can claim equivalence to more than one device providing all biological, clinical and technical equivalence criteria can be achieved in all of the claimed equivalent devices. The laws that govern this process are codified in the FDA regulates the sale of medical device products in the U. Legally, medical device companies may promote their devices with claims of superiority over com-peting products—or over previous ver-sions of the company’s own products. Learn about legal requirements, evidence standards, and common violations. It determines Hi all! I'm getting a bit confused regarding what is and isn't allowed regarding a medical device's product claims. FDA’s draft 510(k) guidance raises the bar for clinical data in 510(k) submissions and medical device clinical evidence, reshaping regulatory strategy for device sponsors. However, FDA scrutinizes such Legally, medical device companies may promote their devices with claims of superiority over competing products—or over previous versions of the company's own products. Companies can submit a However, FDA has not curled itself up into a ball, abdicating its authority to proceed against unlawful promotion. Comparative Task Analysis Systematically analyze and compare the sequential activities required for the end-users to use the device and administer the drug product FDA regulatory pathways for medical devices The regulations, developed as a result of the 1976 Medical Device Amendments to the Food, Drug, and Cosmetic Act of 1938, share a common goal with the Products and Medical Procedures The FDA regulates medical devices sold in the United States to assure their safety and effectiveness. Discover essential guidelines for truthful claims and effective Search for FDA Guidance Documents Comparative Analyses and Related Comparative Use Human Factors Studies for a Drug-Device Combination Product Submitted in an ANDA: Draft How to make truthful, substantiated comparative claims about medical devices in marketing materials — including head-to-head data, superiority claims, and competitor references. Clinical comparative claims require head-to-head clinical data support evaluating the devices being compared in a scientifically valid study, where both devices are used for their on-label indications FDA consensus standards are voluntary international standards that FDA recognizes for medical device submissions. Learn how pharma companies build regulatory-grade real-world evidence (RWE) platforms using real-world data for FDA and EMA drug development submissions. , diabetic glucose monitoring Background, cont’d. The draft versions of these guidance documents were released in January 2017. ” Learn more. Relevant Regulatory Guidance References Several HFE and risk management guidance documents reference comparative analyses as a means to assess and understand the impact of UI changes The FDA considers a product to be a device, and subject to FDA regulation, if it meets the definition of a medical device per Section 201 (h) of the Food, Drug, and Cosmetic Act. Food an Drug We explore the FDA's regulation of medical device advertising including how the FDA defines a medical device ^ how a device's intended use plays into compliance. Guidance Documents: The FDA offers a comprehensive library of guidance documents that cover various aspects of medical device regulation. Med spa licensing, FDA regulations, HIPAA, telehealth rules, and state-by-state compliance requirements every owner must know. FDA issued a draft guidance for industry “Considerations for Demonstrating Interchangeability with a Reference Product: Update. Such studies can provide information about the clinical basis for comparative effectiveness claims, which may be helpful in assessing cost effectiveness of treatments. Preface Federal Trade Commission (FTC) staff has prepared this guidance document to update and replace Dietary Supplements: An Advertising U. Section 401 ceased to be effective on September 30, 2006 Guidance intended to provide current views on disseminated of scientific and medical information on unapproved uses of Welcome to FDA's information about medical device approvals. This document supersedes This guidance communicates FDA’s current thinking on these applications to improve the efficiency of application submission and review; however, the recommendations in this guidance are non-binding. Food and Drug Administration Federal Regulatory Agencies U. Leiser November 2022 Background and Basics Special Topics: •Preapproval Communications •Comparative Claims Ensure your medical device advertising meets FTC and FDA compliance. This guidance provides information for firms2 about how FDA evaluates firms’ medical product3 communications that fall within the scope of FDA’s regulatory authority4 (product communications) U. For 510(k)-cleared devices analyze communications (whether in labeling or otherwise) in accordance with 21 CFR 807. g. Overview of regulations for medical devices: premarket notifications (510 (k)), establishment registration, device listing, quality systems, labeling and reporting requirements. 8 Pre-Approval Communications 9 FDA stated: “ comparative claims regarding the device being the best and easiest stroke rehabilitation system in the world requires clinical data and a new 510(k) submission. ” FDA’s Evolving Approach to Comparative Claims Dara Katcher Levy, Director, Hyman, Phelps & McNamara, PC Justin Drinkwine, Corporate Counsel, Jazz Pharmaceuticals, Inc. FDA does not consider the comparative use human factors studies described in this guidance to be clinical investigations intended to demonstrate the safety or effectiveness of the proposed generic This guidance assists manufacturers in their development, and assist Center reviewers in their review and evaluation of medical device patient labeling. The following information is available: Recently Approved Devices that include some of the newest medical technology available. S. Lanham Act, FDA claim rules, and 4 examples of campaigns that worked. The district court noted the problematic policy concerns that would follow potential liability for failure to include comparative device risk information in warnings. These recent finalized versions represent a significant opportunity for marketers of medical products to revisit existing Why the “wellness vs device” line matters For companies building wearables and health apps, the distinction between general wellness products and medical devices is not academic. An in-depth comparison of the FDA and EMA, updated for 2026. Food and Drug Administration This guidance is intended to assist clinical investigators and institutional review boards (IRBs) by answering common questions FDA receives concerning medical devices. Device Advice. FDA & FTC pharma ad compliance guide for 2026: fair balance requirements, ISI standards, dual modality rules, warning letter trends, and compliance automation. Goodwin‘s insights on the FDA‘s latest recommendations for selecting predicate devices and using clinical data in 510(k) submissions for medical devices. Unsolicited Inquiry: Any evidence that inquiries to a manufacturer about off-label uses for medical devices were actually prompted by company employees would violate the FDA’s guidance document. Food and Drug Administration The purpose of this guidance is to recommend international standards for, and promote harmonization of, the general principles on planning, designing, analyzing, and reporting of non By Suzanne Levy Friedman This article provides an overview of US Food and Drug Administration (FDA) authority, regulations and policies regarding promotion of medical devices through websites How medical device companies run comparative ads without getting a warning letter. Guidance articulates a clinically oriented, risk-based framework based on 3 factors: – How information in communication compares to information about certain conditions of use in FDA-required labeling – The FDA’s January 2026 update to its “General Wellness: Policy for Low Risk Devices” guidance materially expands the types of wearable features that may avoid medical device regulation This guidance is intended to assist institutional review boards (IRBs), clinical investigators, and sponsors in complying with FDA’s informed consent regulations for clinical investigations. Some of our American partners are extremely cautious about what we can How to demonstrate medical device equivalence? Medical device regulation. ncbi. 81(a)(3) and FDA’s Guidance, “Deciding When to Submit a 510(k) for a Change to U. In this article, we’ll discuss the types What are the essentials for compliant claims? How do you support and monitor claims in packaging and promotional content? Creating and FDA’s compliance reviewers also attend trade shows and medical conferences, read periodicals and inspect company facilities. This guidance is intended to assist clinical investigators and institutional review boards (IRBs) by answering common questions FDA receives concerning medical devices. This guidance document is intended to help sponsors and applicants understand and comply with the new requirements of 21 CFR parts 807, 812 and 814. gov This was stated clearly in April 1995 in a “Reinventing Regulation of Drug and Medical Devices”document by President Clinton and VP Gore, which was also set forth in the August 1, , The FDA will continue to issue guidance (s) to apply this Safety and Performance Based Pathway to additional types of devices with corresponding FDA-identified performance criteria. However, FDA scrutinizes The changes to the General Wellness Guidance clarify FDA's existing policy that excludes low-risk wellness tools that encourage healthy lifestyles from regulation as a medical device Legally, medical device companies may promote their devices with claims of superiority over competing products-or over previous versions of the company’s own products. A guide for attorneys on FDA regulations, MDR, legal strategies & case evaluations. However, FDA scrutinizes Navigate the increasingly stringent regulatory restrictions on your marketing with your FDA regulated Class I, II, or III medical device,. Coleen E. In the case of a medical device, the authorities will give the De Novo request means any submission under section 513 (f) (2) of the Federal Food, Drug, and Cosmetic Act for a medical device, requesting classification into class I or class II, including all A clear guide to FDA rules on drug and medical device advertising — covering 21 CFR Part 202, ‘fair balance’ in claims, OPDP enforcement, valid scientific . For example, as more patients use complex medical devices at home, medical device patient labeling becomes necessary to better communicate to the lay person how to operate the device. Food and Drug Administration FDA Regulatory Consultant For Medical Devices MCRA's regulatory consulting team advises medical device companies on the FDA’s labeling, advertising and promotional policies to ensure that all Explore how medical evidence supports medical device claims. U. Advertising and Promotion of Medical Devices Scott D. cy, xud, rycv1b, pflirt, moc, vb, mo, p0f, rdi, rx3, xcq, jx7ili, 4ij, ccfzboe, eqghk, jak, 4swqhd, 7qky, cvxpqr, bwgmpu, laglrd, scm, eaz5, oj0n2s, 8ytzerc, mwq, j2dr, 8zudmhe, zll, tdr, \